KIDNEY INJURY MOLECULE-1 (KIM-1) EXPRESSION LEVEL AND CHRONIC GLOMERULONEPHRITIS ACTIVITY

Download full text PDF
Issue: 
5
Year: 
2016

M. Brovko; A. Pulin, Candidate of Medical Sciences; Professor L. Kozlovskaya, MD; V. Sholomova; T. Kustova, S. Roshchupkina I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia

The paper presents the current view of the value of kidney injury molecule-1 (KIM-1) in chronic glomerulonephritis and describes clinical cases.

Keywords: 
nephrology
kidney injury molecule-1 (KIM-1)
chronic glomerulonephritis
nephrotic syndrome



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Chebotareva N.V., Bobkova I.N., Kozlovskaja L.V. i dr. Opredelenie ek kretsii s mochoj monotsitarnogo hemotaksicheskogo proteina-1 i transformi-rujuschego faktora rosta-β1 u bol'nyh hronicheskim glomerulonefritom kak metod otsenki protsessov fibrogeneza v pochke // Klin. nefrol. – 2010; 3: 51–5.
  2. Kaplan G., Totsuka A., Thompson P. et al. Identification of a surface . glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus // EMBO J. – 1996; 15: 4282–96.
  3. Meyers J., Sabatos C., Chakravarti S. et al. The TIM gene family regulates autoimmune and allergic et al. Regulation of T-cell immunity by T-cell immunoglobulin and mucin domain proteins // Transplantation. – 2007; 84 (Suppl.): 12–6.
  4. Meyers J., Sabatos C., Chakravarti S. et al. The TIM gene family regulates autoimmune and allergic diseases // Trends Mol. Med. – 2005; 11: 362–9.
  5. Ichimura T., Asseldonk E., Humphreys B. et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells // J. Clin. Invest. – 2008; 118: 1657–68.
  6. Ichimura T., Bonventre J., Bailly V. et al. M. Kidney injury molecule-1 (KIM-6. 1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury // J. Biol. Chem. – 1998; 273: 4135–42
  7. Zhang Z., Humphreys B., Bonventre J. Shedding of the urinary biomarker 7. kidney injury molecule-1 (KIM-1) is regulated by MAP kinase and juxtamembrane region // J. Am. Soc. Nephrol. – 2007; 18: 2704–14.
  8. Zhang P., Rothblum L., Han W. et al. Kidney injury molecule-1 expression in 8. transplant biopsies is a sensitive measure of cell injury // Kidney Int. 2008; 73: 608–14.
  9. Liangos O., Perianayagam M., Vaidya V. et al. Urinary N-acetyl-beta-d-9. glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure // J. Am. Soc. Nephrol. – 2007; 18: 904–1212.
  10. van Timmeren M., Van Den Heuvel M., Bailly V. et al. Tubular kidney injury 10. molecule-1 (KIM-1) in human renal disease // J. Pathol. – 2007; 212: 209–17.
  11. Sexton D., Al-Rabia M., Blaylock M. et al. Phagocytosis of apoptotic 11. eosinophils but not neutrophils by bronchial epithelial cells // Clin. Exp. Allergy. – 2004; 34: 1514–24.
  12. Kuehn E., Park K., Somlo S. et al. Kidney injury molecule-1 expression in 12. murine polycystic kidney disease // Am. J. Physiol. Renal. Physiol. – 2002; 283 (6): 1326–36.
  13. Perez-Rojas J. et al. Mineralocorticoid receptor blockade confers 13. renoprotection in preexisting chronic cyclosporine nephrotoxicity // Am. J. Physiol. Renal. Physiol. – 2007; 292 (1): 131–9.
  14. van Timmeren M. et al. Tubular kidney injury molecule-1 in protein-overload 14. nephropathy // Am. J. Physiol. Renal. Physiol. – 2006; 291 (2): 456–64.
  15. Kramer A. et al. Reduction of proteinuria in adriamycin-induced nephropathy 15. is associated with reduction of renal Kidney injury molecule-1 (Kim-1) over time // Am. J. Physiol. Renal. Physiol. – 2009; 296 (5): 1136–45.
  16. Waanders F., van Timmeren M., Stegeman C. et al. Kidney injury molecule-1 16. in renal disease // J. Pathol. – 2010; 220 (1): 7–16
  17. Schroppel B. et al. Tubular expression of KIM-1 does not predict delayed 17. function after transplantation // J. Am. Soc. Nephrol. – 2010; 21 (3): 536–42.
  18. Waanders F. et al. Effect of renin-angiotensin-aldosterone system inhibition, 18. dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial // Am. J. Kidney Dis. – 2009; 53 (1): 16–25.
  19. van Timmeren M. et al. High urinary excretion of kidney injury molecule-1 19. is an independent predictor of graft loss in renal transplant recipients // Transplantation. – 2007; 84 (12): 1625–30.
  20. Humphreys B., Xu F., Sabbisetti V. Chronic epithelial kidney injury 20. molecule-1 expression causes murine kidney fibrosis // J. Clin. Invest. – 2013; 123 (9): 4023–35.
  21. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic 21. cytokines – CXC and CC chemokines // Adv. Immunol. – 1994; 55: 97–179.
  22. Tesch G., Mainfert S., Schwarting A. et al. MCP-1-dependent leukocytic 22. infiltrates are responsible for autoimmune disease in MRL-Faslpr mice // J. Exp. Med. – 1999; 190: 1813.
  23. Bobkova I., Chebotareva N., Kozlovskaia L. et al. Urine excretion of a 23. monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression // Ter. Arkh. – 2006; 78 (5): 9–14.
  24. Basile D., Donohoe D., Roethe K. et al. Renal ischemic injury results in 24. permanent damage to peritubular capillaries and influences long-term function // Am. J. Physiol. Renal. Physiol. – 2001; 281 (5): 887–99.
  25. Ichimura T. et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell 25. adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury // J. Biol. Chem. – 1998; 273 (7): 4135–42.
  26. Sizing I. et al. Epitope-dependent effect of anti-murine TIM-1 monoclonal 26. antibodies on T cell activity and lung immune responses // J. Immunol. – 2007; 178 (4): 2249–61.
  27. Fukushima A. et al. Antibodies to T-cell Ig and mucin domain-containing 27. proteins (Tim)-1 and -3 suppress the induction and progression of murine allergic conjunctivitis // Biochem. Biophys. Res. Commun. – 2007; 353 (1): 211–6.
  28. Feng B. et al. Disruption of T-cell immunoglobulin and mucin domain 28. molecule (TIM)-1/TIM4 interaction as a therapeutic strategy in a dendritic cell-induced peanut allergy model // J. Allergy Clin. Immunol. – 2008; 122 (1): 55–61.
  29. Sonar S. et al. Antagonism of TIM-1 blocks the development of disease in 29. a humanized mouse model of allergic asthma // J. Clin. Invest. – 2010; 120 (8): 2767–81.
  30. Rees A., Kain R. Kim-1/Tim-1: from biomarker to therapeutic target? // 30. Nephrol. Dial. Transplant. – 2008; 23 (11): 3394–6.